Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Oct;14(4):544–548. doi: 10.1128/aac.14.4.544

Comparison of Netilmicin and Amikacin in Treatment of Complicated Urinary Tract Infections

Svend Maigaard 1, Niels Frimodt-Möller 1, Paul O Madsen 1
PMCID: PMC352505  PMID: 363053

Abstract

Netilmicin and amikacin, two recently developed aminoglycosides, were compared in a prospective, randomized study of 57 male patients with complicated urinary tract infections. Both drugs were administered intramuscularly every 12 h for 7 to 10 days, netilmicin at 2 mg/kg and amikacin at 7.5 mg/kg. The two groups were comparable as to infecting bacteria and underlying pathology of the urinary tract. No patients had indwelling catheters. All microorganisms isolated were sensitive to both antibiotics. A total of 69% of the patients treated with netilmicin and 57% of the patients treated with amikacin were cured of the infection, as defined by a negative culture at 7 days after discontinuation of treatment. No major side effects were recorded, and no significant changes were noted in parameters of renal function. Of the patients treated with amikacin, 21% experienced temporary local pain at the injection site; no such effect was noted in the netilmicin-treated group. Therefore, netilmicin appeared to be as effective and better tolerated than did amikacin in the treatment of complicated urinary tract infection.

Full text

PDF
544

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Cox C. E. Amikacin Therapy of Urinary tract infections. J Infect Dis. 1976 Nov;134(Suppl):S362–S368. doi: 10.1093/infdis/135.supplement_2.s362. [DOI] [PubMed] [Google Scholar]
  3. Gooding P. G., Berman E., Lane A. Z., Agre K. A review of results of clinical trials with amikacin. J Infect Dis. 1976 Nov;134(Suppl):S441–S445. doi: 10.1093/infdis/135.supplement_2.s441. [DOI] [PubMed] [Google Scholar]
  4. Kantor R. J., Norden C. W. In vitro activity of netilmicin, gentamicin, and amikacin. Antimicrob Agents Chemother. 1977 Jan;11(1):126–131. doi: 10.1128/aac.11.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lode H., Grunert K., Koeppe P., Langmaack H. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis. 1976 Nov;134(Suppl):S316–S322. doi: 10.1093/infdis/135.supplement_2.s316. [DOI] [PubMed] [Google Scholar]
  6. Madsen P. O., Kjaer T. B., Mosegaard A. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin. Urology. 1977 Jun;9(6):635–638. doi: 10.1016/0090-4295(77)90309-0. [DOI] [PubMed] [Google Scholar]
  7. Mathias R. G., Ronald A. R., Gurwith M. J., McCullough D. W., Stiver H. G., Berger J., Cates C. Y., Fox L. M., Lank B. A. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. J Infect Dis. 1976 Nov;134(Suppl):S394–S401. doi: 10.1093/infdis/135.supplement_2.s394. [DOI] [PubMed] [Google Scholar]
  8. McHenry M. C., Wagner J. G., Hall P. M., Vidt D. G., Gavan T. L. Pharmacokinetics of amikacin in patients with impaired renal function. J Infect Dis. 1976 Nov;134(Suppl):S343–S348. doi: 10.1093/infdis/135.supplement_2.s343. [DOI] [PubMed] [Google Scholar]
  9. Meyers B. R., Hirschman S. Z. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1977 Jan;11(1):118–121. doi: 10.1128/aac.11.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Siersbaek-Nielsen K., Hansen J. M., Kampmann J., Kristensen M. Rapid evaluation of creatinine clearance. Lancet. 1971 May 29;1(7709):1133–1134. doi: 10.1016/s0140-6736(71)91873-3. [DOI] [PubMed] [Google Scholar]
  12. Smith C. R., Baughman K. L., Edwards C. Q., Rogers J. F., Lietman P. S. Controlled comparison of amikacin and gentamicin. N Engl J Med. 1977 Feb 17;296(7):349–353. doi: 10.1056/NEJM197702172960701. [DOI] [PubMed] [Google Scholar]
  13. Welling P. G., Baumueller A., Lau C. C., Madsen P. O. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother. 1977 Sep;12(3):328–334. doi: 10.1128/aac.12.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES